News | Coronavirus (COVID-19) | July 28, 2020

ams Accelerates Supply of CT Detector Technology

ams Commended by United Imaging for Accelerated Supply of Unprecedented Levels of Essential CT Detectors to Fight Covid-19 (SARS-CoV-2)

ams Commended by United Imaging for Accelerated Supply of Unprecedented Levels of Essential CT Detectors to Fight Covid-19 (SARS-CoV-2)

July 28, 2020 — ams, a leading worldwide supplier of high performance sensor solutions, has been thanked by long-term customer, United Imaging, for its outstanding contribution to helping hospitals in China to diagnose respiratory complications of some of the first Covid-19 (SARS-CoV-2) patients. United Imaging’s computed tomography (CT) scanners were needed quickly by hospitals in China and increasingly around the world. At this time of continuing medical crisis in a number of countries, ams is delivering its industry-leading CT detector technology to United Imaging. Both companies together demonstrated their corporate social responsibility by supporting CT examination in frontline hospitals to fight the threat of Covid-19 (SARS-CoV-2) to China and the world.

United Imaging develops and produces advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging, diagnosis and treatment. Founded in 2011 with global headquarters in Shanghai, the company has subsidiaries and R&D centers across China and around the world. On January 27, the company sent an emergency notification letter to suppliers: ams immediately responded to resume work and production, overcoming numerous logistical difficulties to supply sensor components to United Imaging with urgently needed CT and digital radiology equipment for use by medical teams on the front line of the Covid-19 (SARS-CoV-2) outbreak.

An official letter of appreciation from Lv Yun-Lei, VP Procurement of United Imaging said: “As a leading enterprise in China’s high-end medical equipment industry, United Imaging’s medical equipment has been widely used in hospitals across the country, including Huoshenshan Hospital, Leishenshan Hospital, and mobile hospitals in Wuhan, making outstanding contributions to fighting the epidemic, and winning high praise from the governments, hospitals, and people in the affected areas. It is ams’ strong sense of social responsibility, together with United Imaging and the people of the whole country, that caused a turning point in this war without gunfire.”

With the epidemic in China effectively controlled, the country is now facing huge demand to fulfill foreign exports. United Imaging is no exception, with customers in several countries requesting medical supplies to deal with their own outbreaks of the virus. This has resulted in an unprecedented demand for the fast delivery of United Imaging equipment not only domestically, but internationally. To achieve this, United Imaging states that it intends to work jointly with ams to make greater contributions to healthcare in China and worldwide.

Pinglu Chen, Senior Vice President Greater China, ams, responded: “This is a great example of fulfilling our vision of delivering technology innovation for a better lifestyle. Like United Imaging, I firmly believe that with the efforts of governments and the people of all countries, we will be able to control Covid-19 (SARS-CoV-2). On behalf of the whole team at ams, I am proud to have made this and other contributions to detecting and addressing this deadly virus, and in doing so improving medical outcomes for people around the world.”

Computed Tomography (CT)

Medical professionals are constantly pushing CT imaging equipment manufacturers to provide higher resolution images, which allow for more accurate diagnosis of a patient’s condition, while at the same time keeping X-ray dosage to a minimum, to reduce the risk to the patient’s health when undergoing a scan.

New generations of detector solutions from ams are helping equipment makers to achieve both these goals, giving reductions in X-ray doses while producing motion-free CT images.

The reason for the ams detectors’ superior performance is that they reduce noise in the sensitive analog signal chain between the photodiode and the high-speed ADC. ams technologies also eliminate the dead time that is required in the operation of many ADCs, maximizing the linearity of the output.

For more information: https://ams.com/medical-health

Related Content

A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

Feature | Computed Tomography (CT) | July 27, 2020
There has been tremendous growth in the field of cardiovascular...
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine latera

(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine lateral sampling (requiring dithering); the filled circles show the data that are sampled without dithering.

News | Computed Tomography (CT) | July 24, 2020
July 24, 2020 — A computed tomography (CT) sca
A and B, Lung ultrasound images obtained with convex (A) and linear (B) probes. Multiple confluent B-lines (arrows), patchy pulmonary consolidation (asterisk, B), and thickened pleural line (between arrowheads, A) are visualized. C, Chest CT image shows reticular and interlobular septal thickening and patchy, focal opacities associated with architectural distortion. This patient was classified in critical group and was assigned to severe group for statistical analysis.

A and B, Lung ultrasound images obtained with convex (A) and linear (B) probes. Multiple confluent B-lines (arrows), patchy pulmonary consolidation (asterisk, B), and thickened pleural line (between arrowheads, A) are visualized. C, Chest CT image shows reticular and interlobular septal thickening and patchy, focal opacities associated with architectural distortion. This patient was classified in critical group and was assigned to severe group for statistical analysis.

News | Coronavirus (COVID-19) | July 23, 2020
July 23, 2020 — 
Clearing medical device cybersecurity requirements from DoD delivers even more safety assurance for customers
News | Cybersecurity | July 23, 2020
July 23, 2020 — Carestream Health’s ImageView software has received the Risk Management Framework Authority to Operat
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.  http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html

In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study.

 

News | Coronavirus (COVID-19) | July 22, 2020 | Dave Fornell, Editor
July 22, 2020 — One of the first studies has been published that looks at the use of...
RSNA 2020: Human Insight/Visionary Medicine, will be held as an all-virtual event, Nov. 29 – Dec. 5, 2020
News | RSNA | July 22, 2020
July 22, 2020 — Registration is now open for the Radiological Society of North America (...
MICI is a collaboration between The MarkeTech Group and AHRA that measures the confidence level of medical imaging administrators across the U.S.

Getty Images

Feature | Radiology Imaging | July 22, 2020 | By Melinda Taschetta-Millane